These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 31202357)

  • 1. Translation of cancer immunotherapy from the bench to the bedside.
    Guo Q; Huang F; Goncalves C; Del Rincón SV; Miller WH
    Adv Cancer Res; 2019; 143():1-62. PubMed ID: 31202357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nobel committee honors tumor immunologists.
    Rotte A; D'Orazi G; Bhandaru M
    J Exp Clin Cancer Res; 2018 Oct; 37(1):262. PubMed ID: 30376854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune checkpoint inhibitors win the 2018 Nobel Prize.
    Huang PW; Chang JW
    Biomed J; 2019 Oct; 42(5):299-306. PubMed ID: 31783990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer immunotherapy crowned with Nobel Prize in Physiology or Medicine awarded to James Allison and Tasuku Honjo].
    Teillaud JL
    Med Sci (Paris); 2019 Apr; 35(4):365-366. PubMed ID: 31038115
    [No Abstract]   [Full Text] [Related]  

  • 5. Putting the Immunologic Brakes on Cancer.
    Wolchok J
    Cell; 2018 Nov; 175(6):1452-1454. PubMed ID: 30500529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.
    Petitprez F; Meylan M; de Reyniès A; Sautès-Fridman C; Fridman WH
    Front Immunol; 2020; 11():784. PubMed ID: 32457745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging immune checkpoints in the tumor microenvironment: Implications for cancer immunotherapy.
    Wei G; Zhang H; Zhao H; Wang J; Wu N; Li L; Wu J; Zhang D
    Cancer Lett; 2021 Jul; 511():68-76. PubMed ID: 33957184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From the time in the wilderness to the Nobel Prize in Physiology or Medicine awarded to James Allison and Tasuku Honjo: the Long March of cancer immunotherapy].
    Fridman WH; Teillaud JL
    Med Sci (Paris); 2019 Apr; 35(4):367-373. PubMed ID: 31038116
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of immune checkpoint therapy for cancer.
    Fritz JM; Lenardo MJ
    J Exp Med; 2019 Jun; 216(6):1244-1254. PubMed ID: 31068379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Nobel Prize-worthy pursuit: cancer immunology and harnessing immunity to tumour neoantigens.
    Altmann DM
    Immunology; 2018 Nov; 155(3):283-284. PubMed ID: 30320408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of miRNAs in immune responses and immunotherapy in cancer.
    Cortez MA; Anfossi S; Ramapriyan R; Menon H; Atalar SC; Aliru M; Welsh J; Calin GA
    Genes Chromosomes Cancer; 2019 Apr; 58(4):244-253. PubMed ID: 30578699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing.
    Li Z; Song W; Rubinstein M; Liu D
    J Hematol Oncol; 2018 Dec; 11(1):142. PubMed ID: 30577797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers.
    Mushtaq MU; Papadas A; Pagenkopf A; Flietner E; Morrow Z; Chaudhary SG; Asimakopoulos F
    J Immunother Cancer; 2018 Jul; 6(1):65. PubMed ID: 29970158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structures of Immune Checkpoints: An Overview on the CD28-B7 Family.
    Liu W; Zang X
    Adv Exp Med Biol; 2019; 1172():63-78. PubMed ID: 31628651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.
    Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons learned from the blockade of immune checkpoints in cancer immunotherapy.
    Li X; Shao C; Shi Y; Han W
    J Hematol Oncol; 2018 Feb; 11(1):31. PubMed ID: 29482595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [At the crossroads of cancer].
    Chouaib S
    Bull Cancer; 2013 Jun; 100(6):569-74. PubMed ID: 23735599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting tumor-associated immune suppression with selective protein kinase A type I (PKAI) inhibitors may enhance cancer immunotherapy.
    Hussain M; Shah Z; Abbas N; Javeed A; Mukhtar MM; Zhang J
    Med Hypotheses; 2016 Jan; 86():56-9. PubMed ID: 26804598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New principles of cancer therapy give new hope for oncological patients.
    Bernadic M; Duchon R; Aziri R; Mladosievicova B
    Bratisl Lek Listy; 2019; 120(1):15-18. PubMed ID: 30685987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAR T Cell Therapy Progress and Challenges for Solid Tumors.
    Stern LA; Jonsson VD; Priceman SJ
    Cancer Treat Res; 2020; 180():297-326. PubMed ID: 32215875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.